Language selection

Search

Details for: NIMENRIX

Company: PFIZER CANADA ULC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02402904NIMENRIXMENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A; MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C; MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135; MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y; TETANUS TOXOID5 MCG / 0.5 ML; 5 MCG / 0.5 ML; 5 MCG / 0.5 ML; 5 MCG / 0.5 ML; 44 MCG / 0.5 MLPOWDER FOR SOLUTIONINTRAMUSCULAR
02402904NIMENRIXMENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A; MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C; MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135; MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y; TETANUS TOXOID5 MCG / 0.5 ML; 5 MCG / 0.5 ML; 5 MCG / 0.5 ML; 5 MCG / 0.5 ML; 44 MCG / 0.5 MLKITINTRAMUSCULAR
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Basis of Decision
Regulatory Decision Summary

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: